PAG
TXG icon

Pinnacle Advisory Group’s 10x Genomics TXG Stock Holding History

Pinnacle Advisory Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$937K Buy
+5,179
New +$894K 0.04% 123

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
MCAV
Meritech Capital Associates V Palo Alto, California $151M AUM 26.94% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Pinnacle Advisory Group's TXG Position: Q1 2021 in Review

Pinnacle Advisory Group opened a new position in 10x Genomics (TXG) in Q1 2021: 5,179 shares worth $937K. The stake represents 0.04% of the portfolio and ranks #123 among its holdings.

324 funds tracked by Wall St. Rank hold TXG as of Q1 2021.

  • Pinnacle Advisory Group held 5,179 shares of 10x Genomics worth $937K as of Q1 2021.
  • 10x Genomics was a new Pinnacle Advisory Group position in Q1 2021.
  • 10x Genomics made up 0.04% of Pinnacle Advisory Group's portfolio in Q1 2021, its #123 holding.
  • 324 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2021.

Based on Pinnacle Advisory Group's 13F filing for Q1 2021, filed 12 May 2021.